Monthly Archives: February 2013

Clarity Elan Style

The announcement that Elan has sold its Tysabri part-ownership to Biogen-Idec raises some interesting questions about Elan’s direction.  What better way to assess their strategy than by their own words? June 3, 2010 (Elan PR, from their Chairman) “Mr. Martin … Continue reading

Posted in Big Pharma, Uncategorized | Tagged , , | Leave a comment